Impact of 2019 EAS/ESC dyslipidaemia guidlines on management of FH patients: Reclassification of risk and LDL-C goal attainement in the Latvian registry

Daiņus Gilis; Georgijs Ņesterovičs; Rūta Meiere; Terauda E.; Elizabete Tērauda; Vita Šaripo; Artis Ērglis; Andrejs Ērglis; Gustavs Latkovskis

doi:10.1016/j.atherosclerosis.2020.10.652

Impact of 2019 EAS/ESC dyslipidaemia guidlines on management of FH patients: Reclassification of risk and LDL-C goal attainement in the Latvian registry

Daiņus Gilis
, Georgijs Ņesterovičs
, Rūta Meiere
, Terauda E.
, Elizabete Tērauda
, Vita Šaripo
, Artis Ērglis
, Andrejs Ērglis
, Gustavs Latkovskis

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Atherosclerosis
Volume	315
DOIs	https://doi.org/10.1016/j.atherosclerosis.2020.10.652
Publication status	Published - 2020

OECD Field of Science

3. Medical and Health Sciences

Access to Document

10.1016/j.atherosclerosis.2020.10.652

Cite this

@article{e6d6b005ed4a422e8fe77b8b6cec7c1e,

title = "Impact of 2019 EAS/ESC dyslipidaemia guidlines on management of FH patients: Reclassification of risk and LDL-C goal attainement in the Latvian registry",

author = "Daiņus Gilis and Georgijs Ņesterovi{\v c}s and Rūta Meiere and Terauda E. and Elizabete Tērauda and Vita {\v S}aripo and Artis Ērglis and Andrejs Ērglis and Gustavs Latkovskis",

year = "2020",

doi = "10.1016/j.atherosclerosis.2020.10.652",

language = "English",

volume = "315",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Impact of 2019 EAS/ESC dyslipidaemia guidlines on management of FH patients: Reclassification of risk and LDL-C goal attainement in the Latvian registry

AU - Gilis, Daiņus

AU - Ņesterovičs, Georgijs

AU - Meiere, Rūta

AU - E., Terauda

AU - Tērauda, Elizabete

AU - Šaripo, Vita

AU - Ērglis, Artis

AU - Ērglis, Andrejs

AU - Latkovskis, Gustavs

PY - 2020

Y1 - 2020

UR - https://www.atherosclerosis-journal.com/article/S0021-9150(20)31234-X/fulltext

U2 - 10.1016/j.atherosclerosis.2020.10.652

DO - 10.1016/j.atherosclerosis.2020.10.652

M3 - Meeting abstract

SN - 0021-9150

VL - 315

JO - Atherosclerosis

JF - Atherosclerosis

ER -

Impact of 2019 EAS/ESC dyslipidaemia guidlines on management of FH patients: Reclassification of risk and LDL-C goal attainement in the Latvian registry

OECD Field of Science

Access to Document

Other files and links

Cite this